Using lung ultrasound to improve outcomes in cardiac surgery patients
Influence of Ultrasound Examination of the Lungs on the Prognosis and Postoperative Outcomes in Cardiac Surgical Patients
NA · Saint Petersburg State University, Russia · NCT06377449
This study is testing if using lung ultrasound can help doctors find lung problems earlier in patients after heart surgery compared to regular X-rays and CT scans.
Quick facts
| Phase | NA |
|---|---|
| Study type | Interventional |
| Enrollment | 186 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Saint Petersburg State University, Russia (other) |
| Locations | 1 site (Saint Petersburg, Sankt-Peterburg) |
| Trial ID | NCT06377449 on ClinicalTrials.gov |
What this trial studies
This interventional study aims to evaluate the effectiveness of lung ultrasound in identifying early postoperative pulmonary complications in patients undergoing cardiac surgery with cardiopulmonary bypass. Participants will receive lung ultrasound examinations on postoperative days 1 and 3, and the results will be compared to traditional imaging methods like X-rays and CT scans. The study seeks to determine if ultrasound can provide more accurate and timely detection of interstitial pulmonary edema, potentially influencing mid-term patient outcomes.
Who should consider this trial
Good fit: Ideal candidates are patients scheduled for open heart surgery with cardiopulmonary bypass between December 15, 2023, and December 15, 2024.
Not a fit: Patients who have undergone reoperations, have a history of lung cancer, or suffer from severe chronic obstructive pulmonary disease or chronic kidney disease may not benefit from this study.
Why it matters
Potential benefit: If successful, this approach could lead to improved postoperative care and outcomes for cardiac surgery patients by enabling earlier detection of complications.
How similar studies have performed: While the use of ultrasound in various medical fields has shown promise, this specific application in cardiac surgery is relatively novel and has not been extensively tested.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * open heart surgery with cardiopulmonary bypass (CPB) between 15 December 2023 and 15 December 2024 * signed informed consent for participation in the study Exclusion Criteria: * reoperations on the open heart with CPB * surgical procedures on lungs and lung cancer in the anamnesis * chronic obstructive pulmonary disease, stage III * chronic kidney disease, stages 4 and 5 * patients with low Risk Score profile by the Society of Thoracic Surgeons
Where this trial is running
Saint Petersburg, Sankt-Peterburg
- Saint Petersburg State University Clinic — Saint Petersburg, Sankt-Peterburg, Russia (RECRUITING)
Study contacts
- Study coordinator: Aleksei A Filippov, MD, PhD
- Email: aleksei.filippov.chb@gmail.com
- Phone: +79819553639
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Ischemic Heart Disease, Aortic Stenosis, Severe, Aortic Insufficiency, Mitral Stenosis, Mitral Insufficiency, Mitral Stenosis With Insufficiency, Tricuspid Insufficiency, Ascending Aortic Aneurysm